Daniella Beckman

2022

In 2022, Daniella Beckman earned a total compensation of $1.5M as Chief Financial Officer at Tango Therapeutics, a 52% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$191,614
Option Awards$897,750
Salary$425,100
Other$2,415
Total$1,516,879

Beckman received $897.8K in option awards, accounting for 59% of the total pay in 2022.

Beckman also received $191.6K in non-equity incentive plan, $425.1K in salary and $2.4K in other compensation.

Rankings

In 2022, Daniella Beckman's compensation ranked 2,204th out of 5,753 executives tracked by ExecPay. In other words, Beckman earned more than 61.7% of executives.

ClassificationRankingPercentile
All
2,204
out of 5,753
62nd
Division
Manufacturing
1,192
out of 3,133
62nd
Major group
Chemicals And Allied Products
515
out of 1,419
64th
Industry group
Drugs
475
out of 1,320
64th
Industry
Pharmaceutical Preparations
347
out of 966
64th
Source: SEC filing on April 24, 2023.

Beckman's colleagues

We found two more compensation records of executives who worked with Daniella Beckman at Tango Therapeutics in 2022.

2022

Barbara Weber

Tango Therapeutics

Chief Executive Officer

2022

Alan Huang

Tango Therapeutics

Chief Scientific Officer

News

In-depth

You may also like